TRIM59 and metabolic dysfunction-associated steatotic liver disease: In current study, we observed highly expression of TRIM59 in NAFLD tissues, and then elucidated the promoting role of TRIM59 in cell lipid or fat accumulation with palmitic acid (PA)-treated L02 cells.